EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Geographical variability in dabigatran dosing within New Zealand

Liam T Berryman iD, Paul K L Chin iD, Lorna J Pairman iD, Milan Sundermann, Matthew Doogue

Internal Medicine Journal · 2026-08 · 56 (8) · 1433-1437

DOI: 10.1111/imj.70477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 25.05.2026. Verfasst von Liam T Berryman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Otago, Christchurch, New Zealand. Hauptthemen laut MEDLINE: Dabigatran, Antithrombins. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Otago Future Health Researcher Scholarship, Canterbury Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dabigatran etexilate is an oral anticoagulant with increased risk of bleeding at high drug exposure. It is available in three capsule strengths (75, 110 and 150 mg). We analysed New Zealand dispensing data from 2019 to 2023 to compare use between health districts. Overall use was similar across districts. Canterbury had the highest 75 mg use (22.2 vs 1.6–7.6 people per 10 000 in the other districts). This relates to differences in local guidelines, therapeutic drug monitoring and availability of clinical pharmacology services. It is unknown if there are differences in patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DabigatranAntithrombinsHumansNew ZealandDrug MonitoringDose-Response Relationship, DrugAnticoagulants

Stichwörter der Autor:innen

New Zealandanticoagulantdabigatranpharmacologytherapeutic drug monitoring

Substanzen

DabigatranAntithrombinsAnticoagulants

Autor:innen und Institutionen

  • Department of Medicine, University of Otago, Christchurch, New Zealand.
  • Department of Clinical Pharmacology, Health New Zealand, Christchurch, New Zealand.

ORCID-Profile: Liam T Berryman, Paul K L Chin, Lorna J Pairman

Förderung

  • University of Otago Future Health Researcher Scholarship
  • Canterbury Medical Research Foundation

Zitieren

APA

Berryman, L. T., Chin, P. K. L., Pairman, L. J., Sundermann, M., & Doogue, M. (2026). Geographical variability in dabigatran dosing within New Zealand. Internal Medicine Journal, 56(8), 1433-1437. https://doi.org/10.1111/imj.70477

Vancouver

Berryman LT, Chin PKL, Pairman LJ, Sundermann M, Doogue M. Geographical variability in dabigatran dosing within New Zealand. Internal Medicine Journal. 2026;56(8):1433-1437. doi:10.1111/imj.70477

BibTeX
@article{Berryman2026,
  author = {Berryman, Liam T and Chin, Paul K L and Pairman, Lorna J and Sundermann, Milan and Doogue, Matthew},
  title = {Geographical variability in dabigatran dosing within New Zealand},
  journal = {Internal Medicine Journal},
  year = {2026},
  volume = {56},
  number = {8},
  pages = {1433--1437},
  doi = {10.1111/imj.70477}
}
Kostenlos starten →